跳至主要内容
临床试验/JPRN-UMIN000004749
JPRN-UMIN000004749招募中未知

A study to evaluate the long-term effect of pulmonary hypertension on prognosis, activities of daily living (ADL), cardiac function and pulmonary function in patients with COPD and IPF, respectively, according to baseline severity of pulmonary hypertension and the efficacy and safety of the Tracleer (bosentan hydrate) tablet for prognosis, activities of daily living, cardiac function and pulmonary function in patients with COPD and IIPs, respectively, according to baseline severity of pulmonary hypertension.

Department of Respiratory Medicine, Chiba-Hokusoh Hospital, Nippon Medical School0 个研究点目标入组 160 人开始时间: 2010年12月18日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
40years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients already on bosentan or other drugs for pulmonary hypertension 2) Patients with any disease that can cause right heart overload 3) Patients with hypoxemia (PaO2<60mmHg at rest or after 6 minutes walk). 4) Women who are pregnant or who may be pregnant, and lactating women 5) Patients with moderate or severe liver disorder 6) Patients under treatment with ciclosporin, tacrolimus, or glibenclamide 7) Other patients judged by the investigator to be inappropriate as a subject of this study

研究者

发起方
Department of Respiratory Medicine, Chiba-Hokusoh Hospital, Nippon Medical School

相似试验